RELAX-AHF Mortality Prediction Score Calculator

Clinical calculation support · Verify results before clinical use

Acute heart failure · Clinical tool

This page collects the clinical variables present in the legacy calculator. The original coefficient set and probability equation have not been verified against a reproducible published RELAX-AHF model; a mortality probability is therefore intentionally not generated.

Clinical inputs

Enter the available patient data. Use the original units shown beside each field.

Model unverified

Demographics and vital signs

Laboratory variables

Comorbidities and threshold indicators

Reset form

Clinical context

RELAX-AHF was a randomized trial of serelaxin in selected patients hospitalized with acute heart failure. The trial assessed outcomes through 180 days, but the existence of trial mortality outcomes does not by itself establish the legacy equation on this page as a validated prediction score.

The variables retained in this form reflect those present in the supplied legacy code. They should not be interpreted as a validated model specification, and the threshold flags should not be treated as interchangeable with the continuous measurements.

How to use this page

  • Use the form only to validate and organize the entered values.
  • No predicted mortality percentage, score category, or treatment recommendation is calculated.
  • For clinical risk assessment, use an independently validated instrument appropriate to the patient and setting.

Evidence reviewed

Teerlink JR, Cotter G, Davison BA, et al.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomized, placebo-controlled trial.

The Lancet. 2013;381(9860):29–39.

doi:10.1016/S0140-6736(12)61855-8

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the RELAX-AHF Development Program: Correlation With Outcomes.

Journal of the American College of Cardiology.

doi:10.1016/j.jacc.2012.11.005 · PMID: 23273292

A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.

PubMed record

Clinical disclaimer: This page is not a validated mortality calculator. The legacy coefficients and logistic intercept have not been reproduced from a verifiable publication in this review. Do not use this page to estimate an individual patient's mortality risk, determine disposition, or guide treatment. Clinical decisions require comprehensive assessment and validated tools where appropriate.